| ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome C Ginestier, MH Hur, E Charafe-Jauffret, F Monville, J Dutcher, M Brown, ... Cell stem cell 1 (5), 555-567, 2007 | 4844 | 2007 |
| EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells CG Kleer, Q Cao, S Varambally, R Shen, I Ota, SA Tomlins, D Ghosh, ... Proceedings of the National Academy of Sciences 100 (20), 11606-11611, 2003 | 1982 | 2003 |
| Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity CL Chaffer, ND Marjanovic, T Lee, G Bell, CG Kleer, F Reinhardt, ... Cell 154 (1), 61-74, 2013 | 944 | 2013 |
| CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature Z Miao, KE Luker, BC Summers, R Berahovich, MS Bhojani, A Rehemtulla, ... Proceedings of the National Academy of Sciences 104 (40), 15735-15740, 2007 | 739 | 2007 |
| Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks S Liu, C Ginestier, SJ Ou, SG Clouthier, SH Patel, F Monville, H Korkaya, ... Cancer research 71 (2), 614-624, 2011 | 712 | 2011 |
| Repression of E-cadherin by the polycomb group protein EZH2 in cancer Q Cao, J Yu, SM Dhanasekaran, JH Kim, RS Mani, SA Tomlins, R Mehra, ... Oncogene 27 (58), 7274-7284, 2008 | 658 | 2008 |
| BRCA1 regulates human mammary stem/progenitor cell fate S Liu, C Ginestier, E Charafe-Jauffret, H Foco, CG Kleer, SD Merajver, ... Proceedings of the National Academy of Sciences 105 (5), 1680-1685, 2008 | 584 | 2008 |
| E-cadherin expression in primary carcinomas of the breast and its distant metastases PJ Kowalski, MA Rubin, CG Kleer Breast Cancer Research 5 (6), R217, 2003 | 569 | 2003 |
| Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis Q Pan, CG Kleer, KL Van Golen, J Irani, KM Bottema, C Bias, ... Cancer research 62 (17), 4854-4859, 2002 | 496 | 2002 |
| Discoidin domain receptor tyrosine kinases: new players in cancer progression RR Valiathan, M Marco, B Leitinger, CG Kleer, R Fridman Cancer and Metastasis Reviews 31 (1-2), 295-321, 2012 | 403 | 2012 |
| Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer DR Robinson, S Kalyana-Sundaram, YM Wu, S Shankar, X Cao, B Ateeq, ... Nature medicine 17 (12), 1646-1651, 2011 | 401 | 2011 |
| Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions M Zhou, AM Chinnaiyan, CG Kleer, PC Lucas, MA Rubin The American journal of surgical pathology 26 (7), 926-931, 2002 | 382 | 2002 |
| Protocol for the examination of specimens from patients with invasive carcinoma of the breast SC Lester, S Bose, YY Chen, JL Connolly, ME de Baca, PL Fitzgibbons, ... Archives of pathology & laboratory medicine 133 (10), 1515-1538, 2009 | 374 | 2009 |
| Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis R Mehra, S Varambally, L Ding, R Shen, MS Sabel, D Ghosh, ... Cancer research 65 (24), 11259-11264, 2005 | 371 | 2005 |
| Canonical Wnt signaling regulates Slug activity and links epithelial–mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression ZQ Wu, XY Li, CY Hu, M Ford, CG Kleer, SJ Weiss Proceedings of the National Academy of Sciences 109 (41), 16654-16659, 2012 | 359 | 2012 |
| An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers AK Witkiewicz, A Dasgupta, F Sotgia, I Mercier, RG Pestell, M Sabel, ... The American journal of pathology 174 (6), 2023-2034, 2009 | 343 | 2009 |
| Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board EA Newman, AB Guest, MA Helvie, MA Roubidoux, AE Chang, CG Kleer, ... Cancer 107 (10), 2346-2351, 2006 | 313 | 2006 |
| Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability CG Kleer, KL Van Golen, Y Zhang, ZF Wu, MA Rubin, SD Merajver The American journal of pathology 160 (2), 579-584, 2002 | 308 | 2002 |
| Molecular biology of breast cancer metastasis Inflammatory breast cancer: clinical syndrome and molecular determinants CG Kleer, KL van Golen, SD Merajver Breast Cancer Research 2 (6), 423, 2000 | 292 | 2000 |
| Persistent E-cadherin expression in inflammatory breast cancer CG Kleer, KL van Golen, T Braun, SD Merajver Modern Pathology 14 (5), 458-464, 2001 | 279 | 2001 |
